PL EN


Preferences help
enabled [disable] Abstract
Number of results
Journal
1996 | 4 | 108-115
Article title

Antisense oligonucleotides: from the bench to the patients

Title variants
Languages of publication
EN
Abstracts
EN
We describe here tha current state of progress toward gene-directed antisense-based cancer therapy targeting BCR/ABL, oncogene, primarily from the viewpoint of initial proof-of-concepts studies in animal models of human leukemias and phase I clinical investigations.
Publisher

Journal
Year
Issue
4
Pages
108-115
Physical description
Contributors
References
Document Type
article
Publication order reference
T.Skorski, Kimmel Cancer Center, Thomas Jefferson University, BLSB630, 233 South 10th Street, Philadephia, PA 19107, USA
Identifiers
YADDA identifier
bwmeta1.element.element-from-psjc-1cfc1613-86da-3918-a586-428516de46a5
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.